Choate Investment Advisors Continues to Hold Holdings in Cigna Corporation (CI)

Choate Investment Advisors maintained its stake in Cigna Corporation (NYSE:CI) during the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,046 shares of the health services provider’s stock at the end of the second quarter. Choate Investment Advisors’ holdings in Cigna Corporation were worth $342,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CI. Spot Trading L.L.C. lifted its position in Cigna Corporation by 108.9% during the first quarter. Spot Trading L.L.C. now owns 1,998 shares of the health services provider’s stock valued at $293,000 after purchasing an additional 24,425 shares during the period. LS Investment Advisors LLC lifted its position in Cigna Corporation by 11.3% during the first quarter. LS Investment Advisors LLC now owns 11,079 shares of the health services provider’s stock valued at $1,623,000 after purchasing an additional 1,121 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Cigna Corporation by 4.4% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 66,723 shares of the health services provider’s stock valued at $9,774,000 after purchasing an additional 2,829 shares during the period. Swiss National Bank lifted its position in Cigna Corporation by 25.6% during the first quarter. Swiss National Bank now owns 976,474 shares of the health services provider’s stock valued at $143,044,000 after purchasing an additional 199,100 shares during the period. Finally, World Asset Management Inc lifted its position in Cigna Corporation by 13.0% during the first quarter. World Asset Management Inc now owns 27,053 shares of the health services provider’s stock valued at $3,963,000 after purchasing an additional 3,112 shares during the period. Institutional investors own 87.96% of the company’s stock.

In related news, Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total value of $230,667.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 153,168 shares of the business’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the transaction, the chief executive officer now owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 223,821 shares of company stock valued at $38,506,877. Company insiders own 1.30% of the company’s stock.

Shares of Cigna Corporation (NYSE:CI) traded up 0.44% during mid-day trading on Friday, hitting $186.05. 2,462,011 shares of the stock traded hands. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $188.36. The firm has a 50 day moving average of $179.52 and a 200 day moving average of $165.10. The stock has a market cap of $46.84 billion, a price-to-earnings ratio of 21.47 and a beta of 0.43.

Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.98 EPS. On average, equities analysts expect that Cigna Corporation will post $10.02 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/09/17/choate-investment-advisors-continues-to-hold-holdings-in-cigna-corporation-ci.html.

A number of research analysts recently weighed in on the stock. Piper Jaffray Companies restated a “buy” rating and set a $191.00 price objective on shares of Cigna Corporation in a research report on Sunday. BidaskClub upgraded shares of Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Morgan Stanley increased their price objective on shares of Cigna Corporation from $188.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Royal Bank Of Canada restated a “buy” rating and set a $185.00 price objective on shares of Cigna Corporation in a research report on Wednesday, August 9th. Finally, Zacks Investment Research downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $182.59.

Cigna Corporation Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply